News and Events
The pharmaceutical world is constantly evolving so it is paramount to stay up-to-date. Keep abreast of all Quinta’s announcements, insights and activities, as well as wider industry news right here.
18 July 2023
Challenges of a large-scale study of breast cancer
Our bioanalytical experts and a high-profile client team up for the development of a new therapy for breast cancer.
29 June 2023
EU funding for Quinta-Analytica laboratory in Brno (CZ) was succesfully completed.
After two years, the project to finance new equipment for the Quinta-Analytica laboratory in Brno was successfully completed. The investment from European Regional Development Fund was used in this project.
22 June 2023
Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies
EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency
15 June 2023
Novavax & Conscio: Behind the Scenes of Vaccine Development
Discover how the Conscio Group and renowned vaccine manufacturer Novavax collaborate behind the scenes to ensure quality and efficiency in vaccine production.
8 June 2023
Ekolab And Conscio Group Join Forces
Ekolab joins the Conscio Group, enhancing our analytical capabilities and solidifying our position in pharmaceutical, nutrition, and technology solutions.
8 June 2023
Clinical Tips – Drug Interactions in Advanced Clinical Trial Design
Drug interactions play a key role in the design of clinical trials. Learn how we investigate such interactions when conducting pharmacokinetic/bioequivalence studies and while offering end-to-end support throughout the process.
6 April 2023
Transdermal Patches, Films and Topicals – Putting the Skin in the Game
Today we talk about novel drug delivery systems and in vitro testing techniques. Learn about our work with transdermal patches, orally dissolving films, topical products and Franz cell testing.
23 March 2023
Clinical Tips – Benefits of Sequential Designs in Bioequivalence Studies
Discover the power of sequential designs for bioequivalence studies, a crucial step in generics development: Their practical implementation, statistical analysis, and the well-being of the volunteers.
23 March 2023
A Prescription Against EU Medicine Shortages – Outsourcing Stabilities
We highlight the reasons behind current EU drug shortages and the key role CROs and outsourced stability testing play in diversifying drug production.
27 January 2023
Pharmaceutical Offshore Outsourcing in the USA: Opportunities & Misconceptions
Dr. Jeffrey Kiel, founder and CEO of Kiel Laboratories, talks about offshore outsourcing in the USA and working with Quinta-Analytica.
5 January 2023
From Houston to Munich – Innovation & Compounding
Pharma innovators often outsource demanding projects to specialist CROs. Gus Bassani of US-based PCCA and Markus Dachtler of Conscio's German subsidiary Gen-Plus, share lessons from their collaboration.
7 December 2022
Quinta’s Another Two Successful FDA Inspections
We at Quinta-Analytica are proud to announce the successful completion of not 1 but 2 FDA inspections at our Prague and Brno sites. Thanks for your trust and support!
24 November 2022
The Secret Behind 25 Years of Excellence
Quinta-Analytica's 25th Anniversary give us the chance to look back at our successful trajectory of proactiveness, technical expertise and improvement in the company of Dr Miroslav Ryska, mass spectrometry expert and founder of Quinta.
24 November 2022
Quinta-Analytica + Olga Havel Foundation – Helping to Help Others
We are proud to announce that Quinta-Analytica has donated 100,000 CZK to the Olga Havel Foundation for the support of six families with members in need of neurorehabilitation.
24 November 2022
Nitrosamine Analogues: Stepping up to a new Challenge
Have you heard about Nitrosamine Analogues? Did you know even if a tested API is free of nitrosamine analogues, its related drug product may still contain high amounts of these new impurities? Keep reading to learn more!
24 November 2022
New Stability Models for Faster & Better Shelf Life Estimations
Are you a pharma company in need of stability testing but have just too many candidates to screen with conventional ICH assays? We at Quinta-Analytica can offer you accurate stability data 3 times faster than usual! Find out more below.
24 November 2022
CPHI Frankfurt 2022: See you there!
Quinta-Analytica is attending CPHI 2022 in Frankfurt
24 November 2022
Clinical Tips: Linear & non-linear PK
QUINTA is well-known for its state-of-the-art equipment and facilities used to perform clinical trials and bioanalytical services under GCP/GLP; but today our experts wish to talk about pharmacokinetics and statistical evaluations, an important part of their day to day work which doesn't always get the attention it deserves. Click and keep reading!
24 November 2022
Clinical Tips: Intra- and Inter-subject Variability
Interested in clinical study design? Today's Clinical Tips series focuses on intra- and inter-subject variability, crucial concepts for the correct calculation of sample size.
24 November 2022
Clinical Tips: Bioequivalences with urinary data
Volunteers participating in trials at our clinical unit are sometimes surprised to discover that samples collected during the studies are not always blood but can also involve other biological fluids such as urine. Keep reading to learn more about our clinical R&D activities.
24 November 2022
ADC characterisation: When small & large molecules collide
Quinta-Analytica is among the few CROs offering GCP/GLP/GMP services for biologics. We and our valued biotech client SOTIO wish to share our experience with antibody-drug conjugates, the toughest biologics.
24 November 2022
Gen-Plus + Conscio Partnership
Today we proudly announce that Gen-Plus GmbH & Co. KG, a Munich-based pharma R&D and manufacturing expert, has become a new member of the Conscio Group.
3 November 2022
Stability Chambers
As everyone in the pharma world knows, stability testing is one of the most crucial steps in the development of new drug products.
12 May 2022
Liquid Chromatography Apparatus Just Got Even Better.
The introduction of Ultra-High Performance Liquid Chromatography was a significant milestone in the evolution of LC, and is certainly a very powerful tool for today’s chromatographer